Economic consequences in real life of allergen immunotherapy in asthma, rhinitis and dermatitis. Revista Alergia México, [S. l.], v. 63, n. 4, p. 323–333, 2016. DOI: 10.29262/ram.v63i4.238. Disponível em: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/238. Acesso em: 24 sep. 2026.